TGF-β Inhibitor SB431542 Promotes the Differentiation of Induced Pluripotent Stem Cells and Embryonic Stem Cells into Mesenchymal-Like Cells
Due to their potential for tissue engineering applications and ability to modulate the immune system and reduce inflammation, mesenchymal stem cells (MSCs) have been explored as a promising option for the treatment of chronic diseases and injuries. However, there are problems associated with the use...
Saved in:
| Main Author: | Alessander Leyendecker Junior |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2018/7878201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of the TGF-β/Smad3 pathway in pancreatic cancer cell growth and stem cell characteristics
by: Yanling Zhang, et al.
Published: (2025-08-01) -
A competitive protein interaction network buffers Oct4‐mediated differentiation to promote pluripotency in embryonic stem cells
by: Silvia Muñoz Descalzo, et al.
Published: (2013-10-01) -
Lost in translation: pluripotent stem cell‐derived hematopoiesis
by: Mania Ackermann, et al.
Published: (2015-07-01) -
Generation of parathyroid glands from pluripotent stem cells
by: Mayuko Kano
Published: (2025-08-01) -
A pluripotent stem cell atlas of multilineage differentiation
by: Sophie Shen, et al.
Published: (2025-07-01)